Commitments and Contingencies (Tables)

6 Months Ended

Jun. 30, 2020

Commitments and Contingencies Disclosure [Abstract]

Summary of Commitments and Contingencies

Commitments and contingencies are described below and summarized by the following table:

	Total (1)		2020		2021		2022		2023		2024		Thereafter
Key clinical research trial obligations	$	2,251,000	$	167,000	$	2,084,000	$	—	$	—	$	—	$	—
BLA consulting services		1,145,000		—		458,000		687,000		—		—		—
Statistical analysis and programming consulting services		325,000		60,000		265,000		—		—		—		—
Employment agreements		1,704,000		442,000		783,000		466,000		13,000		—		—
Commercial insurance premium financing agreement		1,347,000		888,000		459,000		—		—		—		—
	$	6,772,000	$	1,557,000	$	4,049,000	$	1,153,000	$	13,000	$	—	$	—

(1) Not included in the commitments and contingencies table above are the monthly principal and interest payments of $23,000 that would be due under the PPP loan if it is not forgiven by the SBA (see Note 6).

Schedule of further detail of the CRO contract

	June 30, 2020
Original contract (based on 724 patients)	$	6,180,000
Amendment to contract (based on 1,034 patients)		4,075,000
Total Contract	$	10,255,000
Initial deposit (included in original contract amount)	$	861,000
Amendment to deposit		699,000
Expenses incurred applied to deposit		(1,344,000)
Remaining Deposit (applied to future expenses)	$	216,000
Expenses incurred/accrued (includes expenses applied to deposit)	$	8,171,000
Total future commitment	$	2,084,000

Summary of reconciliation of the Company's undiscounted payments for its facility lease and the carrying amount of the lease liability

The following table provides a reconciliation of the Company’s remaining undiscounted payments for its facility lease and the carrying amount of the lease liability presented in the balance sheet as of June 30, 2020:

	Facility Lease Payments		2020		2021		2022		2023		2024		Thereafter
Remaining Facility Lease Payments	$	1,513,000	$	169,000	$	345,000	$	355,000	$	364,000	$	280,000	$	—
Less: Discount Adjustment		(170,000)
Total lease liability	$	1,343,000
Lease liability-current portion	$	272,000
Long-term lease liability	$	1,071,000

Lease Expense

The following table provides a reconciliation of the Company’s remaining ROU asset for its facility lease presented in the balance sheet as of June 30, 2020:

	Right-of-Use Asset
Balance as of December 31, 2019	$	1,003,000
Amortization		(88,000)
Balance as of June 30, 2020	$	915,000

The Company recorded lease expense in the respective periods is as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2020		2019		2020		2019
Lease expense	$	66,000	$	65,000	$	132,000	$	131,000